Journal: Orthopedic Research Online Journal PDF
Published: Februaru 01, 2019 Volume: 5 Issue: 1
Authors: Dahryn Trivedi, Snehasis Jana
Citation: Dahryn T, Snehasis J. Anti-Rheumatoid Arthritis (RA) Action of Biofield Energy Treatment Using Synovial Sarcoma Cell Line (SW982).Ortho Res Online J. 5(1). OPROJ.000602.2019. DOI: 10.31031/OPROJ.2019.05.000602
- 133 Views
- 6 Downloads
The aim of the present research investigation was to monitor the effect of Consciousness Energy Healing based DMEM medium in a synovial sarcoma cell line (SW982) for evaluation of bone health (anti-rheumatoid arthritis) potential using inflammatory parameter interleukin-8 (IL-8). The test item (DMEM) was divided into two parts. One part was represented as the untreated test item without any Biofield Energy Treatment, while the other portion was defined as the Biofield Energy Treated test item, which received the Biofield Energy Healing Treatment by a renowned Biofield Energy Healer, Dahryn Trivedi. MTT assay was used for testing the cell viability and the results showed that the cell viability of SW982 cells was more than 100% with a safe and non-toxic profile. Further, the test item showed a significant (p≤0.001) inhibition of IL-8 secretion by 70.05% under the stimulation of IL-1β in SW982 cells as compared to the untreated DMEM group. Overall, the experimental data revealed the significant potential of the test item against rheumatoid arthritis to reduce inflammation in joints. Thus, it is concluded that Consciousness Energy Healing Treatment significantly inhibits the pro-inflammatory cytokine (IL-8), which showed a potential to act as an anti-rheumatic action in arthritis and other bone inflammatory disorders such as osteoporosis, Paget’s disease of bone, rickets, deformed bones, osteomalacia, osteoma, aging, bone loss, and fractures.
The bone health study for anti-RA activity using SW982 cells demonstrated significant results from Biofield Energy Healing based DMEM in bone health. MTT assay showed significant improvement of cell viability with more than 100% that suggested that the test items were safe and non-toxic in nature. The Biofield Energy Treated test item showed significant inhibition of interleukin-8 (IL-8) by 70.05% in SW982 cells after 24 hours stimulation with the IL-1β as compared to the untreated DMEM group. Overall, the experimental data showed that the Biofield Energy Treated (The Trivedi Effect®) DMEM has a significant impact to improve the pathophysiology of rheumatoid arthritis and could significantly improve the overall bone health. Thus, the Biofield Energy Treated DMEM might be suitable for an alternative media for cell growth. It can also be useful for the management of various bone-related disorders (such as rickets, osteomalacia, osteoporosis, Paget’s disease of bone, etc.), hormonal imbalance, and aging. Besides, it might be useful various immune-related disease conditions (viz. Irritable Bowel Syndrome, Pernicious Anemia, Ulcerative Colitis, Multiple Sclerosis, Aplastic Anemia, Alzheimer’s Disease, Dermatitis, Asthma, Hashimoto Thyroiditis, Hepatitis, Graves’ Disease, Diabetes, Atherosclerosis, Myasthenia Gravis, Parkinson’s Disease, Systemic Lupus Erythematosus, stress, etc.).